Isaac Zentner

Associate Director Process Development • Carisma Therapeutics

Isaac Zentner is the Associate Director of the Vector Group in the Process Development Department at Carisma Therapeutics. He is currently helping Carisma Therapeutics advance their mission of revolutionizing cancer treatments through their first-in-class first-in-human CAR-Macrophage cell therapy. Isaac received his PhD in Molecular and Cell Biology and Genetics from Drexel University College of Medicine. He utilizes his experience in drug discovery and infectious disease to develop and optimize clinical manufacturing of viral vectors, such as AAV and Adenovirus. He believes in keeping the goal of ‘improving patient outcomes’ as the primary motivator in all aspects of his biomedical research

Also Speaking

Miranda Neville

Vice President Global Operations & Delivery • Autolus

Benoit Bossuge

Head of Strategic Sourcing • CRISPR Therapeutics

David Barrett

Chief Executive Officer • American Society for Gene and Cell Therapy (ASGCT)

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.